115
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system

, , , , &
Pages 488-496 | Received 02 Sep 2011, Accepted 06 Dec 2011, Published online: 09 Jan 2012

References

  • Nucci M, Anaissie E. Emerging fungi. Infect Dis Clin North Am 2006; 20: 563–579.
  • Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695–704.
  • Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009. J Infect 2010; 60: 331–337.
  • Maschmeyer G, Calandra T, Singh N, Wiley J, Perfect J. Invasive mould infections: a multi-disciplinary update. Med Mycol 2009; 47: 571–583.
  • Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood 1997; 90: 999–1008.
  • Nucci M, Anaissie EJ, Queiroz-Telles F, . Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98: 315–319.
  • Muhammed M, Coleman JJ, Carneiro HA, Mylonakis E. The challenge of managing fusariosis. Virulence 2011; 2: 91–96.
  • Patterson TF, Mackool BT, Gilman MD, Piris A. Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected]. N Engl J Med 2009; 361: 287–296.
  • Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005; 40(Suppl. 6): S401–408.
  • Vagace JM, Sanz-Rodriguez C, Casado MS, . Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis 2007; 7: 40.
  • Stanzani M, Vianelli N, Bandini G, . Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006; 53: e243–246.
  • Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) 2011; 90: 69–80.
  • Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 2006; 5: 387–398.
  • Artal-Sanz M, de Jong L, Tavernarakis N. Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol J 2006; 1: 1405–1418.
  • Breger J, Fuchs BB, Aperis G, . Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 2007; 3: e18.
  • Moy TI, Ball AR, Anklesaria Z, . Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA 2006; 103: 10414–10419.
  • Sifri CD, Begun J, Ausubel FM. The worm has turned – microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 2005; 13: 119–127.
  • Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 2007; 3: e101.
  • Mylonakis E, Idnurm A, Moreno R, . Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 2004; 54: 407–419.
  • Tang RJ, Breger J, Idnurm A, . Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun 2005; 73: 8219–8225.
  • Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009; 8: 1750–1758.
  • Pujol N, Zugasti O, Wong D, . Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog 2008; 4: e1000105.
  • Lee KZ, Kniazeva M, Han M, Pujol N, Ewbank JJ. The fatty acid synthase fasn-1 acts upstream of WNK and Ste20/GCK-VI kinases to modulate antimicrobial peptide expression in C. elegans epidermis. Virulence 2010; 1: 113–122.
  • Pukkila-Worley R, Mylonakis E. From the outside in and the inside out: antifungal immune responses in Caenorhabditis elegans. Virulence 2010; 1: 111–112.
  • Zugasti O, Ewbank JJ. Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat Immunol 2009; 10: 249–256.
  • Pukkila-Worley R, Ausubel FM, Mylonakis E. Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog 2011; 7: e1002074.
  • Simonsen KT, Moller-Jensen J, Kristensen AR, . Quantitative proteomics identifies ferritin in the innate immune response of C. elegans. Virulence 2011; 2: 120–130.
  • Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S. Toll-like receptor signal transduction. Exp Mol Med 2007; 39: 421–438.
  • Gil ML, Gozalbo D. TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect 2006; 8: 2299–2304.
  • Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011; 29: 1–21.
  • Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807–869.
  • Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320–344.
  • Liberati NT, Fitzgerald KA, Kim DH, . Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc Natl Acad Sci USA 2004; 101: 6593–6598.
  • Troemel ER, Chu SW, Reinke V, . p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2006; 2: e183.
  • Shivers RP, Pagano DJ, Kooistra T, . Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans. PLoS Genet 2010; 6: e1000892.
  • O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC. Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci USA 1998; 95: 2044–2049.
  • O'Donnell K, Sutton DA, Fothergill A, . Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol 2008; 46: 2477–2490.
  • O'Donnell K, Gueidan C, Sink S, . A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol 2009; 46: 936–948.
  • O'Donnell K, Sutton DA, Rinaldi MG, . Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48: 3708–3718.
  • McCluskey K, Wiest A, Plamann M. The Fungal Genetics Stock Center: a repository for 50 years of fungal genetic research. J Biosci 2010; 35: 119–126.
  • Couillault C, Pujol N, Reboul J, . TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 2004; 5: 488–494.
  • Tenor JL, Aballay A. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep 2008; 9: 103–109.
  • Yeates GW, Bongers T, De Goede RG, Freckman DW, Georgieva SS. Feeding habits in soil nematode families and genera-an outline for soil ecologists. J Nematol 1993; 25: 315–331.
  • Vu TT, Sikora RA, Hauschild R. Effects of endophytic Fusarium oxysporum towards Radopholus similis activity in absence of banana. Commun Agric Appl Biol Sci 2004; 69: 381–385.
  • Voss KA, Riley RT, Norred WP, . An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect 2001; 109(Suppl. 2): 259–266.
  • Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev 2003; 16: 497–516.
  • Jain A, Mohan J, Singh M, Goswami BK. Potentiality of different isolates of wilt fungus Fusarium oxysporum collected from rhizosphere of tomato against root-knot nematode Meloidogyne incognita. J Environ Sci Health B 2008; 43: 686–691.
  • Shimada A, Fujioka S, Koshino H, Kimura Y. Nematicidal activity of beauvericin produced by the fungus Fusarium bulbicola. Z Naturforsch C 2010; 65: 207–210.
  • Athman SY, Dubois T, Coyne D, . Effect of endophytic Fusarium oxysporum on host preference of Radopholus similis to tissue culture banana plants. J Nematol 2006; 38: 455–460.
  • Kokkonen M, Ojala L, Parikka P, Jestoi M. Mycotoxin production of selected Fusarium species at different culture conditions. Int J Food Microbiol 2010; 143: 17–25.
  • Waskiewicz A, Golinski P, Karolewski Z, . Formation of fumonisins and other secondary metabolites by Fusarium oxysporum and F. proliferatum: a comparative study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010; 27: 608–615.
  • Reverberi M, Ricelli A, Zjalic S, Fabbri AA, Fanelli C. Natural functions of mycotoxins and control of their biosynthesis in fungi. Appl Microbiol Biotechnol; 87: 899–911.
  • Johnson CH, Ayyadevara S, McEwen JE, Shmookler Reis RJ. Histoplasma capsulatum and Caenorhabditis elegans: a simple nematode model for an innate immune response to fungal infection. Med Mycol 2009; 47: 808–813.
  • Legrand C, Anaissie E, Hashem R, . Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis 1991; 164: 944–948.
  • Means TK, Mylonakis E, Tampakakis E, . Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009; 206: 637–653.
  • Okoli I, Coleman JJ, Tampakakis E, . Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 2009; 4: e7025.
  • Moy TI, Conery AL, Larkins-Ford J, . High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 2009; 4: 527–533.
  • Chaturvedi S, Rajkumar SS, Li X, . Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in bats. PLoS One 2011; 6: e17032.
  • Coleman J, Muhammed M, Kasperkovitz P, Vyas J, Mylonakis E. Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biology 2011; 115: 1279–1289.
  • Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DP. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J Infect Dis 2007; 196: 1860–1864.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.